Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitamin B12 + vitamin D is a combination dietary supplement composed of vitamin B12 (most commonly as cyanocobalamin) and vitamin D (most commonly as cholecalciferol, or vitamin D3). Both are essential vitamins: vitamin B12 is necessary for DNA synthesis, red blood cell formation, and neurological function, while vitamin D plays a key role in calcium absorption and bone health. Combination products are formulated for patients with or at risk of deficiency in both vitamins, with the intention of supporting neurological, musculoskeletal, and general metabolic health. The mechanism of action is nutrient replacement: vitamin B12 acts as a coenzyme in DNA and methionine synthesis, while vitamin D enhances calcium and phosphate absorption via its action on the vitamin D receptor, affecting gene transcription in target tissues. Combination use may provide improved outcomes over single-nutrient supplementation in certain populations at risk for multiple deficiencies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitamin B12 + vitamin D.